The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To review factors influencing placebo response and clinical trial outcome in depression, and suggest ways to optimize trial success in mood disorders. DATA SOURCES: PubMed searches were conducted by cross-referencing the terms depression, depressive with placebo, clinical trial, and clinical trials for studies published in English between 1970 and September 2013. STUDY SELECTION: Relevant abstracts were identified in PubMed, including clinical trials, quantitative studies, and qualitative research. We obtained and reviewed relevant articles and utilized their information to synthesize the present review. DATA EXTRACTION: Included articles were grouped in the following areas of relevance: (1) biological validity of illness, (2) baseline severity of illness, (3) chronicity of the index episode of depression, (4) age of participants, (5) medical and psychiatric comorbidity, (6) probability of receiving placebo, (7) use of prospective treatment phases (lead-in) (8) dosing schedule, (9) trial duration, (10) frequency of follow-up assessments, and (11) study outcome measure. RESULTS: Several key elements emerge as critical to the ultimate success of a clinical trial, including the probability of receiving placebo, study duration, dosing schedule, visit frequency, the use of blinded lead-in phases, the use of centralized raters, illness severity and duration, and comorbid anxiety. CONCLUSIONS: Our increasing understanding of the placebo response in clinical trials of major depressive disorder lends to a, gradually, more predictable phenomenon and, hopefully, to one that becomes lesser in magnitude and variability. Several elements have emerged that seem to play a critical role in trial success, gradually reshaping the design of clinical, translational, as well as mechanistic studies in depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aaronson, S. T., Sears, P., Ruvuna, F., Bunker, M., Conway, C. R., Dougherty, D. D., Reimherr, F. W., Schwartz, T. L., & Zajecka, J. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16010034 · Cited by 381
“While not exactly equivalent to an expectation effect, a potential for a “placebo” effect is diminished by the patients’ elevated baseline illness severityandchronicity (25).”
Timmerby, N., Andersen, J. H., Søndergaard, S., Østergaard, S. D., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457131 · Cited by 134
Self-citationSanacora, G., Johnson, M. R., Khan, A., Atkinson, S. D., Riesenberg, R. R., Schronen, J. P., Burke, M. A., Zajecka, J. M., Barra, L., Su, H.-L., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.224 · Cited by 120
“Several of these factors, including extended study duration, lack of a placebo runin, and increased number of sites, have previously been shown to influence placebo response in published studies of MDD (Iovieno and Papakostas, 2012; Khan et al, 2002b; Khin et al, 2011; Papakostas et al, 2015).”
BackgroundStubbs, B., Vancampfort, D., Rosenbaum, S., Ward, P. B., Richards, J., Ussher, M., & Schuch, F. B. (2016) · Sports Medicine · doi:10.1007/s40279-015-0441-5 · Cited by 66
“In the case of medication, control groups typically receive an inert pill with no active ingredient as the placebo [15] and, in order to demonstrate its effectiveness, the active medication has to show evidence of a treatment effect beyond that seen in the placebo response.”
BackgroundLieb, K., Dreimüller, N., Wagner, S., Schlicht, K., Falter, T., Neyazi, A., Müller-Engling, L., Bleich, S., Tadić, A., & Frieling, H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00511 · Cited by 54
“One explanation for the different response prediction patterns between severely and less severely depressed patients could lie in the fact that more severely affected patients show less placebo response rates (52) and that drug effects in those patients are “true” drug effects based on neurobiological underpinnings as…”
Background
Metadata
- Authors
- Papakostas, G. I., Østergaard, S. D., & Iovieno, N.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2015-02-03
- Volume
- 76
- Issue
- 04
- Pages
- 456-466
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1964393249
- Cited by
- 55
- References
- 0
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder. https://app.cochat.ai/papers/10.4088/jcp.14r09297
- The paper
- Papakostas, G. I., Østergaard, S. D., & Iovieno, N. (2015). The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.14r09297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.